Specialists at the NYU Langone Transplant Institute provide our patients with exceptional care that incorporates the latest technological advancements in heart, kidney, liver, lung, and pancreas transplantation. We are also among the few hospitals that perform heart–lung, heart–kidney, liver–kidney, and kidney–pancreas transplants. Our facilities include modern testing sites and dedicated inpatient surgical and intensive care units, as well as a multidisciplinary outpatient transplant clinic.
Transplants and COVID-19
If you or a loved one has had or is awaiting an organ transplant, you may have questions about COVID-19. For questions about your care, contact your transplant coordinator. For general information on COVID-19 and transplants, visit the American Society of Transplantation (AST).Visit the AST COVID-19 Page
In 2022, we performed 600 organ transplants. This is more than any other hospital in New York State, according to the United Network for Organ Sharing. Our heart, kidney, liver, lung, and pancreas transplant programs are approved by the Centers for Medicare & Medicaid Service (CMS), which means they have met the stringent volume, process, quality, and survival outcome requirements of CMS regulation.
We are the nation’s premier program for heart, kidney, and lung transplant, as evidenced by data published by the Scientific Registry of Transplant Recipients (SRTR), which tracks epidemiological data and statistics related to solid-organ transplant in the United States.
According to SRTR data, our program has achieved the following milestones:
These achievements demonstrate our ability to provide transplant as a treatment for people with the most complex diagnoses.
Transplant Referrals at NYU Langone App
Medical professionals seeking to refer a patient can contact doctors at our Transplant Institute using our app: Transplant Referrals at NYU Langone. Download the app from the App Store or Google Play.
As leaders in the field, our physicians are committed to developing new treatment strategies in transplantation medicine. We are at the forefront of clinical research. We focus on creating innovative techniques to care for people who have life-threatening heart, liver, lung, kidney, or pancreas disease.
We offer expertise in the following types of transplants:
Additionally, NYU Langone experts are pioneers in the field of face transplant: Specialists in the Hansjörg Wyss Department of Plastic Surgery performed the most extensive face transplant to date and the first in New York State as well as the world’s first successful face and bilateral hand transplant.
NYU Langone is among the few institutions in the United States that offers pulmonary thromboendarterectomy, the recommended treatment for a specific type of pulmonary hypertension called chronic thromboembolic pulmonary hypertension.
Our team includes surgeons and physicians who specialize in hepatology, nephrology, cardiology, endocrinology, infectious diseases, pulmonology, radiology, and rehabilitation. Our nurse coordinators receive specialized training in transplantation, and our fellows are part of a program accredited by the American Society of Transplant Surgeons. We also have dedicated social workers, pharmacists, nutritionists, and financial coordinators to help guide you and your family through the complex and nuanced transplant process.
This team approach to transplant care reflects our center’s unwavering dedication to personalized and comprehensive medical care. We recognize that each patient has unique transplant needs. Our physicians and support staff collaborate to ensure that our patients get the specialized care that they deserve.
NYU Langone infectious diseases experts provide comprehensive care for Transplant Institute patients throughout their transplant journey. In collaboration with our heart, kidney, liver, lung, and pancreas transplant experts and specialists at the Blood and Marrow Transplant Program, they work to reduce the risk of infection and provide the best treatment when it does occur. Services include the following:
Our infectious diseases team also leads NYU Langone’s participation in the HOPE in Action study, through which people who were also HIV-positive and need liver or kidney transplants can safely receive organs from deceased donors who were also HIV-positive. The HOPE in Action study may help reduce the amount of time people who are HIV-positive wait for an organ transplant. NYU Langone Transplant Institute also offers a program for directed or anonymous HIV-positive living kidney donations.
Our infectious diseases team is led by Sapna A. Mehta, MD, who is the medical director and clinical director of the Transplant Institute; Henry J. Neumann, MD; Fainareti Zervou, MD; Virginie S. Halpern-Cohen, MD; and Matthew C. Ringer, MD.
The need for donated organs and tissue far outstrips the available supply. The NYU Langone Transplant Institute team is working to increase the number of available organs and tissue and save lives. If you live in New York State, register to become an organ and tissue donor.
317 East 34th Street, 8th Floor, New York, NY, 10016
Review our forms for new and existing NYU Langone patients.
Free Wi-Fi is available to patients and visitors.